To realize its potential, you need to deeply characterize this cell. The Cell Therapy Development Workflow lets you directly link a single cell’s phenotype and function to its genotype. It only takes one cell to create a powerful therapy. We’ll help you find it.
Accelerates the creation of better therapeutics by enabling multiple functional assays to be performed simultaneously on 1000s of individual T cells in a matter of days. Deeply characterize, profile, and map your T cell populations at the single-cell level to directly link behavior to gene expression.
Cells can be selectively cloned into NanoPen™ chambers based on size, viability, and other cell surface markers.
The Opto Cell Therapy Development 1.0 workflow allows you to investigate complex cell-cell interactions. Our ever-expanding portfolio of capabilities includes assays to study secretion of multiple cytokines and track killing kinetics, as well as kits that enable TCR sequencing.
Cytokine assays and cell surface markers can be customized.
Load beads with your target peptide to expand T cells present at frequencies as low as 0.001%. Then, validate and characterize function with our multiple assays.
Now, you can develop therapeutics to mediate more effective tumor destruction by the few T cells that matter.
The TCRseq Well Plate Kit allows you to recover your selected cells from fewer than 10,000 cells, amplify TCR alpha and beta chains, and sequence only the T cells that are potential therapeutics.
From expanding rare, antigen-specific T cells to fully characterizing them, learn how our capabilities are making cell therapy development more efficient.
Review use cases for CAR-T cell screening and TCR discovery.